Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Pharmacogenetics|December 11, 1999
Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the worldH G Xie, C M Stein, R B Kim, et al.Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|June 22, 1999
Clomipramine N-demethylation metabolism in human liver microsomesZ L Wu, S L Huang, D S Ou-Yang, et al.Zhonghua Yi Xue Za Zhi|August 18, 2025
[Longitudinal follow-up in patients with dementia with Lewy bodies: clinical and multimodal imaging characteristics]J R Yao, Y Chang, M Wang, et al.British Journal of Clinical Pharmacology|February 15, 2000
Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese populationD S Ou-Yang, S L Huang, W Wang, et al.The New England Journal of Medicine|October 6, 2001
The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitizationV Dishy, G G Sofowora, H G Xie, et al.Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|May 1, 1997
No correlation between side-chain of propranolol oxidation and S-mephenytoin 4'-hydroxylase activityH G Xie, Z H Xu, S L Huang, et al.Journal of Thrombosis and Haemostasis : JTH|December 30, 2015
Interleukin-10 does not modulate clopidogrel platelet response in miceQ Yin, T Tai, J-Z Ji, et al.Zhonghua Nei Ke Za Zhi|November 30, 2018
[Dementia screening and diagnostic framework in Chinese population]J Z Tian, H G Xie, B Qin, et al.Zhonghua Nei Ke Za Zhi|January 5, 2019
[Screening and diagnostic framework of vascular dementia in Chinese population]J Z Tian, H G Xie, B Qin, et al.Clinical Pharmacology and Therapeutics|December 29, 1999
Effect of the gene dosage of CgammaP2C19 on diazepam metabolism in Chinese subjectsX P Qin, H G Xie, W Wang, et al.Pageof 5